BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 31315994)

  • 1. Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune Interactions.
    Grueso E; Sánchez-Martínez C; Calvo-López T; de Miguel FJ; Blanco-Menéndez N; Fernandez-Estevez M; Elizalde M; Sanchez J; Kourani O; Martin D; Tato A; Guerra M; Andrés G; Almendral JM
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral oncolysis that targets Raf-1 signaling control of nuclear transport.
    Riolobos L; Valle N; Hernando E; Maroto B; Kann M; Almendral JM
    J Virol; 2010 Feb; 84(4):2090-9. PubMed ID: 19939915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of the unordered VP2 n-terminal domain of the parvovirus MVM capsid in nuclear assembly and endosomal enlargement of the virion fivefold channel for cell entry.
    Sánchez-Martínez C; Grueso E; Carroll M; Rommelaere J; Almendral JM
    Virology; 2012 Oct; 432(1):45-56. PubMed ID: 22727830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential phosphorylation and n-terminal configuration of capsid subunits in parvovirus assembly and viral trafficking.
    Gil-Ranedo J; Hernando E; Valle N; Riolobos L; Maroto B; Almendral JM
    Virology; 2018 May; 518():184-194. PubMed ID: 29524834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsidation of a recombinant LuIII parvovirus genome by H1 virus and the fibrotropic or lymphotropic strains of minute virus of mice.
    Maxwell IH; Long CJ; Carlson JO; Rhode SL; Maxwell F
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1175-9. PubMed ID: 8509766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus Capsid Structures Required for Infection: Mutations Controlling Receptor Recognition and Protease Cleavages.
    Callaway HM; Feng KH; Lee DW; Allison AB; Pinard M; McKenna R; Agbandje-McKenna M; Hafenstein S; Parrish CR
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear transport of trimeric assembly intermediates exerts a morphogenetic control on the icosahedral parvovirus capsid.
    Riolobos L; Reguera J; Mateu MG; Almendral JM
    J Mol Biol; 2006 Mar; 357(3):1026-38. PubMed ID: 16469332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mammalian Cell Cycle Regulates Parvovirus Nuclear Capsid Assembly.
    Gil-Ranedo J; Hernando E; Riolobos L; Domínguez C; Kann M; Almendral JM
    PLoS Pathog; 2015 Jun; 11(6):e1004920. PubMed ID: 26067441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear export of the nonenveloped parvovirus virion is directed by an unordered protein signal exposed on the capsid surface.
    Maroto B; Valle N; Saffrich R; Almendral JM
    J Virol; 2004 Oct; 78(19):10685-94. PubMed ID: 15367635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A slender tract of glycine residues is required for translocation of the VP2 protein N-terminal domain through the parvovirus MVM capsid channel to initiate infection.
    Castellanos M; Pérez R; Rodríguez-Huete A; Grueso E; Almendral JM; Mateu MG
    Biochem J; 2013 Oct; 455(1):87-94. PubMed ID: 23875612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary roles of multiple nuclear targeting signals in the capsid proteins of the parvovirus minute virus of mice during assembly and onset of infection.
    Lombardo E; Ramírez JC; Garcia J; Almendral JM
    J Virol; 2002 Jul; 76(14):7049-59. PubMed ID: 12072505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Myristoylation Plays a Role in the Nuclear Entry of the Parvovirus Minute Virus of Mice.
    Yang S; Zhou L; Panté N
    J Virol; 2022 Sep; 96(17):e0111822. PubMed ID: 35950857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced cytoplasmic sequestration of the nuclear export receptor CRM1 by NS2 mutations developed in the host regulates parvovirus fitness.
    López-Bueno A; Valle N; Gallego JM; Pérez J; Almendral JM
    J Virol; 2004 Oct; 78(19):10674-84. PubMed ID: 15367634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental studies of a vaccine formulation of recombinant human VEGF antigen with aluminum phosphate.
    Pérez Sánchez L; Morera Díaz Y; Bequet-Romero M; Ramses Hernández G; Rodríguez Y; Castro Velazco J; Puente Pérez P; Ayala Avila M; Gavilondo JV
    Hum Vaccin Immunother; 2015; 11(8):2030-7. PubMed ID: 25891359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomic Resolution Structure of the Oncolytic Parvovirus LuIII by Electron Microscopy and 3D Image Reconstruction.
    Pittman N; Misseldine A; Geilen L; Halder S; Smith JK; Kurian J; Chipman P; Janssen M; Mckenna R; Baker TS; D'Abramo A; Cotmore S; Tattersall P; Agbandje-McKenna M
    Viruses; 2017 Oct; 9(11):. PubMed ID: 29084163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid.
    Allaume X; El-Andaloussi N; Leuchs B; Bonifati S; Kulkarni A; Marttila T; Kaufmann JK; Nettelbeck DM; Kleinschmidt J; Rommelaere J; Marchini A
    J Virol; 2012 Apr; 86(7):3452-65. PubMed ID: 22258256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution to pathogenicity of the parvovirus minute virus of mice in immunodeficient mice involves genetic heterogeneity at the capsid domain that determines tropism.
    López-Bueno A; Segovia JC; Bueren JA; O'Sullivan MG; Wang F; Tattersall P; Almendral JM
    J Virol; 2008 Feb; 82(3):1195-203. PubMed ID: 18045943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minute virus of mice, a parvovirus, in complex with the Fab fragment of a neutralizing monoclonal antibody.
    Kaufmann B; López-Bueno A; Mateu MG; Chipman PR; Nelson CD; Parrish CR; Almendral JM; Rossmann MG
    J Virol; 2007 Sep; 81(18):9851-8. PubMed ID: 17626084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune responses against minute virus of mice vectors.
    Lang SI; Giese NA; Rommelaere J; Dinsart C; Cornelis JJ
    J Gene Med; 2006 Sep; 8(9):1141-50. PubMed ID: 16800041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.